Bempesta EZ Tablet (Bempedoic acid + Ezetimibe)
Bempesta EZ Tablet combines two lipid-lowering agents — bempedoic acid and ezetimibe — in a single convenient daily tablet.
It is designed for adults with hypercholesterolemia (high cholesterol) who require additional LDL-C (bad cholesterol) reduction despite lifestyle changes and/or statin therapy.
Bempesta EZ is especially useful for patients who cannot tolerate high-dose statins or need further LDL-C lowering beyond what statins alone provide.
Introduction of Bempesta EZ Tablet
Bempesta EZ Tablet contains:
- Bempedoic acid 180 mg: an ATP citrate lyase inhibitor that lowers LDL-C by reducing cholesterol synthesis in the liver.
- Ezetimibe 10 mg: blocks cholesterol absorption in the intestine, further lowering blood cholesterol.
This dual-action fixed-dose combination provides an effective option for high-risk patients who need significant LDL-C reduction or cannot tolerate high-dose statins.
Precautions of Bempesta EZ Tablet:
Before using Bempesta EZ, patients should inform their healthcare provider if they:
- Have severe liver disease
- Have a history of gout or elevated uric acid levels
- Are pregnant, planning pregnancy, or breastfeeding (use is generally not recommended)
- Have tendon disorders or a history of tendon rupture
Not recommended for:
- Patients with active liver disease
- Children and adolescents under 18 years
- Use during pregnancy or breastfeeding unless clearly needed
Periodic monitoring of liver enzymes, uric acid, and LDL-C levels is advised during treatment.
Uses of Bempesta EZ Tablet:
Bempesta EZ Tablet helps manage:
- Primary hypercholesterolemia (familial or non-familial)
- Mixed dyslipidemia
It is typically used: - In combination with statins when LDL-C targets are not achieved
- As monotherapy or with other lipid-lowering therapies in patients intolerant to statins
By combining bempedoic acid (which inhibits cholesterol synthesis in the liver) and ezetimibe (which reduces intestinal cholesterol absorption), Bempesta EZ delivers a complementary, dual mechanism for lowering LDL-C.
Side Effects of Bempesta EZ Tablet:
Most patients tolerate Bempesta EZ well. However, as with any medication, side effects can occur.
Common side effects (usually mild to moderate):
- Muscle pain or discomfort
- Joint pain
- Increased uric acid levels (may rarely trigger gout)
- Gastrointestinal symptoms (diarrhea, nausea)
Less common but potentially serious:
- Elevated liver enzymes
- Tendon rupture (rare; usually in older adults or those on corticosteroids/fluoroquinolones)
- Severe allergic reactions (very rare)
Patients should contact a healthcare provider if they experience unexplained muscle pain, significant joint issues, or symptoms of liver problems (e.g., jaundice, dark urine).
FAQs of Bempesta EZ Tablet:
Q1: Can I take Bempesta EZ instead of a statin?
A: Bempesta EZ is usually used with a statin for better LDL-C reduction, but it may be used alone if you cannot tolerate statins.
Q2: How soon will my cholesterol improve?
A: Significant LDL-C reduction can typically be seen within 4–12 weeks of starting treatment.
Q3: What should I do if I miss a dose?
A: Take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose — do not double up.
Q4: Is this medicine safe for long-term use?
A: Clinical studies support its safety for long-term LDL-C lowering, but regular checkups and lab monitoring are recommended.
Q5: Do I still need to follow diet and exercise recommendations?
A: Yes. Bempesta EZ works best as part of a comprehensive cholesterol-lowering plan, including diet and exercise.
Interactions of Bempesta EZ Tablet:
Bempesta EZ may interact with:
- High-dose statins (e.g., simvastatin >20 mg or pravastatin >40 mg): may increase risk of muscle-related side effects
- Cyclosporine: may raise blood levels of ezetimibe
- Fibrates: combination should be used cautiously
- Warfarin and other anticoagulants: monitor INR closely, as ezetimibe may affect INR
Always inform your healthcare provider about all medicines, supplements, or herbal products you are taking.
| Manufacturer | : | Torrent Pharma, India |
| Trade Name | : | Nexlizet |
| Generic Search | : | Bempedoic acid + Ezetimibe |
| Strength | : | 180mg/10mg |









